High out-of-pocket costs reduce participation in cardiac rehabilitation

Despite the success cardiac rehabilitation has shown at reducing heart-related deaths and hospital readmissions, higher out-of-pocket costs may prevent patients from participating in the program, a Michigan Medicine study suggests.

Opinion | Here’s What I’m Looking For in an Ob/Gyn Residency: Comprehensive Training

Kwock is a first-year medical student. As a first-year medical student, I am interested in a career in obstetrics and gynecology. Yet, even in this

June 5, 2024

Exclusive: David Hough on Lykos’ Path to Resubmission – Psychedelic Alpha

Following Lykos Therapeutics’ receipt of a Complete Response Letter (CRL) from the FDA, which is effectively a rejection of its first shot at approval of MDMA-assisted therapy for PTSD,

September 4, 2024

Novel Anti-Inflammatory Flops for HFpEF, HFmrEF

CHICAGO — The novel myeloperoxidase (MPO) inhibitor mitiperstat failed to improve quality of life or functional capacity in heart failure with mid-range to preserved ejection

November 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.